grant

Role of epicardial adiposity as a local mediator of VT/VF dynamics in donor human hearts

Organization STATE UNIVERSITY OF NEW YORK AT BUFFALOLocation AMHERST, UNITED STATESPosted 10 Mar 2023Deadline 28 Feb 2027
NIHUS FederalResearch GrantFY2025ACRP30 proteinAdipose tissueAnatomic SitesAnatomic structuresAnatomyAnti-InflammatoriesAnti-Inflammatory AgentsAnti-inflammatoryArrhythmiaB cell differentiation factorB cell stimulating factor 2B-Cell Differentiation FactorB-Cell Differentiation Factor GeneB-Cell Differentiation Factor-2B-Cell Stimulatory Factor 2 GeneB-Cell Stimulatory Factor-2BCDFBMIBMI percentileBMI z-scoreBSF-2BSF-2 GeneBSF2BSF2 GeneBeta-2 Gene InterferonBioinformaticsBody TissuesBody mass indexCaM KIICaM PK IICaM kinase IICaMKIICalciumCardiacCardiac ArrhythmiaCatecholaminesCategoriesClinicalCouplingDataDevelopmentDown-RegulationExperimental DesignsFatsFatty TissueFatty acid glycerol estersFutureGene TranscriptionGenetic TranscriptionHPGFHSF GeneHealth Care SystemsHeartHeart ArrhythmiasHeart failureHepatocyte Stimulatory Factor GeneHepatocyte-Stimulating FactorHumanHybridoma Growth FactorHybridoma Growth Factor GeneHyperactivityIFN-beta 2IFNB2IFNB2 GeneIL-6IL-6 GeneIL6IL6 ProteinIL6 geneImmunoblottingIncidenceInflammationInflammatoryInterleukin 6 (Interferon, Beta 2) GeneInterleukin-6Interleukin-6 GeneIsoprenalineIsopropyl NoradrenalineIsopropylarterenolIsopropylnoradrenalineIsopropylnorepinephrineIsoproterenolIsuprelKnowledgeLinkMGI-2MapsMediatingMediatorMentorsModern ManMolecularMorbidityMorbidity - disease rateMyeloid Differentiation-Inducing ProteinNGS MethodNGS systemObesityOpticsOrganOver weightOverweightParacrine CommunicationParacrine SignalingPhasePhysiologicPhysiologicalPlasmacytoma Growth FactorPlayPredispositionPremature Ventricular BeatsPremature Ventricular ContractionsPrevalenceQuetelet indexRNA ExpressionRNA SeqRNA sequencingRNAseqRiskRisk FactorsRoleSiteStimulusSusceptibilitySympathinsTLR proteinTachyarrhythmiasTestingTissuesToll-Like Receptor Family GeneToll-like receptorsTrainingTranscriptionUpregulationVentricularVentricular ArrhythmiaVentricular Ectopic BeatsVentricular ExtrasystoleVentricular FibrillationVentricular Premature ComplexesVentricular Premature ComplicesVentricular TachycardiaWestern BlottingWestern Immunoblottingadipocyte biologyadipocyte complement-related protein 30-kDaadipocyte, C1q and collagen domain containing proteinadiponectinadiposeadiposityapM-1 proteinapM1 (adipose-specific) proteincalcium-dependent CaM kinase IIcalmodulin-dependent protein kinase IIcardiac failurecorpulencecytokinedevelopmentalexperimentexperimental researchexperimental studyexperimentsglobal gene expressionglobal transcription profileinsightinterferon beta 2mortalitymulti-modalitymultimodalitynew markernext gen sequencingnext generation sequencingnextgen sequencingnovel biomarkernovel markerobesity interventionobesity therapyobesity treatmentopticalparacrineprotein blottingsocial rolesudden cardiac deathtachyrhythmiatranscriptometranscriptome sequencingtranscriptomic sequencingwhite adipose tissueyellow adipose tissue
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary:
Ventricular tachyarrhythmias are responsible for 300,000 sudden cardiac deaths a year in the US. The

mechanisms underlying these arrhythmias in the majority of cases are ventricular tachycardia (VT) and/or

ventricular fibrillation (VF). The ever-increasing prevalence of obesity also poses a significant burden on

the health care system with increased morbidity and mortality. Importantly, obesity has been associated

with cardiac arrhythmias with increased risk of sudden cardiac death linked to increased adiposity.

However, the mechanisms by which obesity could result in ventricular arrhythmias (VT/VF) remain

incompletely understood. In this proposal, I plan to use a multimodal and multiscale approach to

characterize VT/VF in donor human hearts associated with sustained obesity. In the mentored phase of

this project, I will use donor hearts to investigate the role of epicardial adiposity in promoting VT/VF via

paracrine signaling, while also getting specialized training in bioinformatics and adipocyte biology. In the

independent phase of this project, I will use donor hearts to investigate the role of epicardial adiposity in

generating arrhythmogenic triggers. The experiments outlined below will advance our understanding of

VT/VF mechanisms and also serve as proof-of-concept for future experiments designed to develop new

markers to predict and treat VT/VF vulnerability in a clinical setting.

Grant Number: 5R00HL148523-05
NIH Institute/Center: NIH

Principal Investigator: Kedar Aras

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →